FDA Approved: DOJOLVI — Supplemental Application (Ultragenyx Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved a supplemental application for DOJOLVI (triheptanoin) submitted by Ultragenyx Pharmaceutical Inc. The action pertains to its use for treating l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long-chain Fatty Acid Oxidation Disorders

Drugs mentioned

• DOJOLVI (triheptanoin)

Snippet

SUPPL AP for DOJOLVI (TRIHEPTANOIN)